A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteers
Covid19-Sources
Impfgegner – Psiram
IgG4 Antibodies Induced by mRNA Vaccines Generate Immune Tolerance to SARS-CoV-2’spike Protein by Suppressing the Immune System
Clinical case definition of post-COVID-19 condition in children: a good start, but improvements are needed
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection
Post-Covid zeigt sich an der DNA
COVID-19 scheint Risiko für Herzinfarkt und Schlaganfall zu steigern
SARS-CoV-2 Can Integrate Into the Genome, Cause Positive Tests | Coronavirus
Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients
Profound Immune Dysregulation and Inflammation Found in Long COVID - but no Autoimmunity - Health Rising
Current understanding of T cell immunity against SARS-CoV-2 - Inflammation and Regeneration
Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November–December 2022
'Long COVID' neurological symptoms traced to infected immune cells: Japan researchers
The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures
Identification of the regulatory mechanism of ACE2 in COVID-19–induced kidney damage with systems genetics approach
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study
Neurocognitive and psychiatric symptoms following infection with COVID-19: Evidence from laboratory and population studies
Covid XBB Variant: Study of 42 XBB.1.16 patients finds 11 had taken 3rd dose | Pune News - Times of India
Is there a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?
An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
Real time analysis of SARS-CoV-2 induced cytolysis reveals distinct variant-specific replication profiles
Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
Long-term cardiovascular outcomes of COVID-19
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
The Effects of COVID-19 on the Placenta During Pregnancy
Pfizer-pharmacokinetics-and-toxicity.pdf | Powered by Box
Immungedächtnis nach SARS-CoV-2: Eine COVID-Infektion schützt mindestens so gut wie die Impfung
Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air - PubMed
Niedrige Vitamin-D-Spiegel bei Patienten mit Post-COVID-Syndrom